By engineering an artificial protein that targets the product of such potentially cancer - causing gene fusions, Hur hopes to trigger immune defense mechanisms that
kill rogue cells harboring the fusions.
Not exact matches
Most researchers assumed that this is because a few
rogue cancer
cells find ways to circumvent the drugs before the whole tumour has been
killed off.
In the new study, researchers used specially designed antibodies in the mice to first wipe out
rogue beta -
cell -
killing T
cells from the immune system.